Comparative trial reveals superior therapeutic efficacy of paclitaxel over cyclophosphamide in advanced ovarian cancer, indicating an optimal first-line regimen.
McGuire, William P.; Hoskins, William J.; Brady, Mark F.; Kucera, Paul R.; Partridge, Edward E.; Look, Katherine Y.; Clarke-Pearson, Daniel L.; Davidson, Martin Author Information
No takes yet. Share an insight, caveat, or question.
McGuire et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: